The emerging therapy of the medication represents a major advance in the care of the condition. Different to existing therapies, tirzepatide affects dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone https://tirzepatidepeptide295150.thenerdsblog.com/48146386/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment